Bioprinting can be defined as additive biofabrication of three-dimensional (3D) tissues and organ constructs using tissue spheroids, capable of self-assembly, as building blocks. The thyroid gland, a relatively simple endocrine organ, is suitable for testing the proposed bioprinting technology. Here we report the bioprinting of a functional vascularized mouse thyroid gland construct from embryonic tissue spheroids as a proof of concept. Based on the self-assembly principle, we generated thyroid tissue starting from thyroid spheroids (TS) and allantoic spheroids (AS) as a source of thyrocytes and endothelial cells (EC), respectively. Inspired by mathematical modeling of spheroid fusion, we used an original 3D bioprinter to print TS in close association with AS within a collagen hydrogel. During the culture, closely placed embryonic tissue spheroids fused into a single integral construct, EC from AS invaded and vascularized TS, and epithelial cells from the TS progressively formed follicles. In this experimental setting, we observed formation of a capillary network around follicular cells, as observed during in utero thyroid development when thyroid epithelium controls the recruitment, invasion and expansion of EC around follicles. To prove that EC from AS are responsible for vascularization of the thyroid gland construct, we depleted endogenous EC from TS before bioprinting. EC from AS completely revascularized depleted thyroid tissue. The cultured bioprinted construct was functional as it could normalize blood thyroxine levels and body temperature after grafting under the kidney capsule of hypothyroid mice. Bioprinting of functional vascularized mouse thyroid gland construct represents a further advance in bioprinting technology, exploring the self-assembling properties of tissue spheroids.
Introduction
The thyroid gland is an endocrine organ required for the production of hormones such as thyroxine (T4) and triiodothyronine (T3). These are essential for normal growth, neurological development and homeostasis. Hypofunctionality of the thyroid gland or its complete removal due to thyroid cancer requires compensation for the lost function [1] . Hypothyroidism is usually treated with synthetic hormone replacement therapy, which is a lifelong treatment [2] . Although hormone replacement therapy does provide a certain level of thyroid hormones it almost completely excludes fine regulation of thyroid status according to current physiological conditions. The use of autologous thyrocytes and thyroid follicles derived from induced pluripotent stem cells opens up the unique possibility of developing a new therapeutic modality to compensate for loss of thyroid function and eliminate the subsequent lifelong dependence of patients on treatment with synthetic hormones [3] .
The recent advances in rapidly emerging threedimensional (3D) bioprinting technology will eventually enable the biofabrication of functional and vascularized tissue from autologous human cells suitable for clinical transplantation [4] . The original concept of robotic layer-by-layer biofabrication of 3D human tissues and organs according to a digital model, using tissue spheroids as building blocks, was proposed more than a decade ago and has been gradually improved [5] [6] [7] [8] . Tissue fusion is a recurrent process during embryonic development [9] and a fundamental biomimetic principle of the proposed 3D bioprinting technology. The fusion of closely placed tissue spheroids enables rapid post-printing self-assembly of the 3D tissue construct.
The anatomical and histological structure of the thyroid gland is relatively simple compared with more complex organs such as the lung, liver or kidney due to the absence of a ductal system. The thyroid gland is thus an attractive target for testing the feasibility of bioprinting technology. The structural and functional unit of the thyroid gland consists of independent thyroid follicles composed of a polarized epithelium surrounded by fenestrated blood capillaries, thereby enabling import of iodine and delivery of thyroid hormones directly into the blood circulation. Branched segments of thyroid arteries and veins are connected with microvessels of multiple angio-follicular units and form the vascularized thyroid gland [10] . Moreover, it has been demonstrated recently that thyroid folliculogenesis is closely associated with and guided by angiogenesis [11] , thus indicating that during thyroid organogenesis the level of vascularization regulates functional differentiation of thyroid follicles.
Vascularization, i.e. the development of a microvascular network, remains a big challenge and a major technological impediment in bioprinting. The microvascular network within an engineered tissue should maintain high cell viability and function, providing the requisite nutrients and oxygen. Without vasculature the size of a bioprinted construct is limited to 200 μm, the diffusion limit of oxygen [12] . Different approaches exist for engineering vascularized tissues. The classical seeding of sacrificial scaffolds with endothelial cells (EC) supported by angiogenic factors has showed promising results but is limited to construction of simple tissues only [13, 14] . Theoretical research based on mathematical modeling and computer simulation [15] , along with a growing body of experimental evidence [16] , strongly indicates that it is possible to bioprint 3D tissue and organ constructs with a built-in intra-organ branched vascular tree using different types of self-assembling vascular tissue spheroids as building blocks. It has been shown that:
(i) solid vascular tissue spheroids could be effectively used for biofabrication of large-diameter extraorgan and intra-organ arterial and venous blood vessels [6] ; (ii) lumenized vascular tissue spheroids could be used for biofabrication of arteriolar and venular vascular segments with intermediate diameter [9, 17] ; and, finally, (iii) prevascularized organospecifc tissue spheroids or adjacently placed endothelial tissue spheroids could be used for bioprinting of tissue constructs with a well-developed microvascular network [18] . We propose a solid scaffold-free approach in which the 'self-assembling spheroid' strategy enables generation of a complex bioprinted tissue construct with a built-in vascular system consisting of hierarchically branched blood vessels.
In our previous paper [19] we demonstrated that tissue spheroids when closely placed in fusion-permissive collagen hydrogel can coalesce and form a toroidlike construct, exactly as predicted by mathematical modeling and computer simulation. Here we report the bioprinting of a functional and vascularized mouse thyroid gland construct using two types of tissue spheroids, thyroid spheroids (TS) and allantoic spheroids (AS), obtained from embryonic thyroid and allantoic tissues, respectively. We demonstrate that EC from AS are endowed with the capacity to completely vascularize thyroid explants, even when the endothelial pool of TS is ablated by selective inhibition of vascular endothelial growth factor receptor 2 (VEGFR2). More importantly, we confirmed the functionality of bioprinted tissue construct in radioiodine-ablated thyroid (hypothyroid mice). Collagen isolation from rat tails and collagen gel preparation Rat tail type I collagen was prepared according to the method described by Rajan et al [20] . The established concentration of collagen in solution was 3.12 mg ml −1
Materials and methods
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. For preparation of collagen gel 890 μl of collagen solution was mixed with 60 μl of 1 M sodium hydroxide, 250 μl of 7.5% sodium bicarbonate and 300 μl of PBS.
Generation of spheroids
Thyroid explants were microdissected from e14.5 mouse embryos as described by Delmarcelle et al [21] . Allantoic tissue was microdissected from e8.5 mouse embryos as described by Drake and Fleming [22] . Dissection was not performed under a sterile atmosphere, so explants and allantoides were washed several times in sterile culture medium. Individual thyroid explants and allantoides were then suspended in 20 μl of complete culture medium and spotted onto the underside of a lid of a 100 mm plastic cell Petri dish. The lids were then inverted and placed onto culture dishes to create hanging drops. SU5416 (VEGFR2 kinase inhibitor) was dissolved in dimethyl sulfoxide (DMSO; 20 mM stock solution) and added at 5 μM to the culture medium for thyroid explants. Control thyroid explants were exposed to the same concentration of vehicle as the test samples. The hanging drop cultures were placed in a humidified atmosphere and cultured at 37°C, 5% CO 2 for 18-24 h. After 18-24 h of culture, the resulting spheroidal thyroid explants and allantoides were used for bioprinting of mouse thyroid gland constructs.
Kinetics of spheroid fusion
Fusion angles between adjacent spheroids were measured as described by Susienka et al [23] . Briefly, fusion angles were measured manually and plotted as a function of time using GraphPad Prism software (GraphPad Software, Inc., La Jolla, CA, USA).
Bioprinting process
To print the thyroid mouse gland construct within the collagen hydrogel spread on a transparent PTFE membrane we used a multifunctional Fabion 3D bioprinter with the turnstile system (see figures 3(A)-(C)). This device consists of the following functional systems: syringe pump; fluidic chip; loading piston (d); trapping piston (e); depositing piston (f) with groove for liquid removal (g) ( figure 3(B) ). The syringe loaded with spheroid suspension was installed into the syringe pump and thus connected to printing head. As soon as the spheroid suspension entered the printing head, the automation system switched the syringe pump on and then switched it off at the moment when spheroids came into contact with trapping piston. The depositing piston (f) moved upward, closing the liquid removal outlet (g) and freeing the channel for spheroid passage; the trapping piston (e) slides downward, opening the passage for spheroids. Then loading piston (d) immediately moved the spheroids rightward and under the depositing piston (f). The depositing piston transported spheroids downward until contact with the printing surface and then returned to its initial position, thus completing one bioprinting cycle. The depositing piston features a groove slightly above the base (g) providing a channel for the draining of liquid. This resource is applied to minimize the amount of liquid being deposited with the tissue spheroids. This section with reduced diameter is positioned between the outlet and the horizontal channel. A vacuum pump removes the liquid, while the tissue spheroids are held in place by the piston itself.
The bioprinter has three air-free syringe dispensers, with one of them able to keep the temperature down to 4°C, one spray nozzle and one pneumatic syringe dispenser. The XY table moves with the resolution of 5 μm and has a heating base with a maximum temperature of 100°C. An experimental single spheroid printer head was developed in house and took the place of one syringe for this experiment. The configuration was designed for convenient incorporation into a bioprinter and subsequent maintenance. The printing head module can be sterilized with either UV irradiation or ethyl alcohol aqueous solution.
To enable collagen hydrogel printing, a special cooling/heating system was developed in house. The system consists of a controllable heating aluminum base (with temperature is ranging from room temperature up to 200°C in steps of 0.1°C) and a cooling system (with temperature ranging from room temperature down to −4°C in steps of 0.1°C) to cool down the syringe contents. Supplementary figure 2(A), available online at stacks.iop.org/BF/9/034105/ mmedia, shows the elements and their connections. The temperature of the syringe was controlled by a cooling system based on a Peltier module. This module allowed cooling by a recirculating liquid that transfers the heat via a coiled bronze tube around the syringe. The cooled syringe kept the collagen mix liquid at 4°C. The base plate uses a cartridge heater to change its temperature up to 100°C. Upon deposition on the heated plate (28°C), the collagen mix polymerizes, allowing a controlled 3D print shape (supplementary figures 2(B), (C)).
Culture of printed thyroid constructs
After the printing, thyroid gland constructs were further cultured within collagen hydrogel spread on the surface of a transparent PTFE membrane for 4 days. The culture medium did not cover the printed constructs but reached the level of the PTFE membrane to allow better oxygenation of the tissue. After 4 days in culture the printed samples were subjected to immunolabeling or grafting. Bright-field imaging was performed on a Nikon Eclipse Ti-E inverted microscope with a Nikon DS-Qi2 camera. Images were processed with NIS-Elements D Research software version 4.0. Photoshop CS5 (Adobe) was used to adjust brightness, contrast and picture size.
Immunolabeling
After the culture, printed constructs were fixed at 4°C in 4% paraformaldehyde in PBS for 2 h, transferred in sucrose 20%/PBS and then embedded in 15% sucrose/7.5% gelatin/PBS. Immunofluorescence on thin tissue sections was performed as described [24] . Primary antibodies and dilutions were as follows: monoclonal mouse anti-E-cadherin at 1:250, rat anti-PECAM at 1:100, monoclonal mouse ant-Ezrin at 1:300, rabbit anti-caspase-3a at 1:200, rabbit antipHH3 at 1:100, monoclonal mouse anti-TTF1 at 1:200. Nuclei were counterstained with Hoechst in PBS during incubation with secondary antibodies. Fluorescence on sections was observed with a Zeiss Cell Axiovert 200 inverted fluorescence microscope or with a Zeiss Cell Observer Spinning Disk (COSD) microscope.
Generation of 131
I-induced hypothyroidism mouse model and transplantation of bioprinted mouse thyroid gland constructs A hypothyroidism mouse model was generated as described previously [25, 26] . Briefly, experimental hypothyroidism was induced by administering 150 μCi of [ crine Plant), then constructs were placed under the renal capsule using a blunt-pointed needle. After surgery, the skin wound was treated with gluten BF-6 (Vertex, Russia). Three and 5 weeks later, the grafted mice were subjected to body temperature measurement, blood sampling for plasma T4 measurements and 5 weeks after transplantation sacrifice for histological examination of the kidneys. All mice were of the CD1 strain. Mice were raised and treated according to the principles of laboratory animal care of the institute's animal ethical committee. All animal experiments and care were in compliance with institutional guidelines and local ethical committees. Animals were maintained on a 12 h light/ 12 h dark schedule (light on at 6 am) and fed with laboratory chow and water ad libitum.
Body temperature measurement
Body temperature was measured in conscious mice using a 'Precision' 841 thermometer (RST, cat. no. RST07841). Animals were restrained and kept motionless to obtain a stable body temperature.
Plasma T4 level measurements
The total T4 level was assayed using a T4 mouse/rat enzyme-linked immunosorbent assay (ELISA) kit (BioVision, cat. no. K7421-100), according to the manufacturer's instructions.
Results
Mathematical modeling and computer simulation of bioprinted thyroid gland In order to demonstrate the feasibility of using tissue spheroids as building blocks in 3D bioprinting we first started with mathematical modeling and computer simulation (figure 1). We capitalized on previously published data and experimental results, which reported 3D bioprinting of sequential segments of a branched vascular tree. Here, for the first time, we report mathematical modeling and computer simulation for biofabrication of a complete intra-organ branched vascular tree including proximal and distal vascular segments. The fusion of spheroids composed of tightly packed epithelial cells or EC was theoretically modeled and simulated. To investigate the fusion process, a multicellular lattice-based model, which describes the interactions between cells based on the differential adhesion hypothesis (DAH), was used [27] . This hypothesis states that: (i) cell adhesion in multicellular systems depends on energy differences between different cell types and (ii) cells in aggregates are motile enough to reach the configuration which minimizes the interfacial energy of the system. In the model, each site of a 3D cubic lattice is occupied either by a cell or a similar-sized volume unit of hydrogel medium. For simulation of the evolution of a multicellular system, the kinetic Monte Carlo (KMC) method was applied [28] . In the KMC method, selfassembly of cells in the cellular aggregate system is described in terms of the transition rates corresponding to possible conformational changes of the system, and then the corresponding time evolution of the system is expressed in terms of these rates. The dynamics of the cells depend on the transition rates of cell swapping with adjacent cells of different type and/ or with hydrogel particles [29, 30] , which are given by the Arrhenius relation. In each step, the transition rates for all possible changes from the current configuration are calculated and then a new configuration is chosen with a probability proportional to the rate of the corresponding transition. Figures 1(A) -(D) depict the computer simulations of the fusion processes between two or three tissue spheroids from different initial settings for bioprinting of the thyroid gland construct. Next, in order to examine the bioprinting settings we modeled the fusion of three TS surrounded by six vascular spheroids which form the core structure of the engineered thyroid construct ( figure 1(E) ). This particular setting was then tested experimentally (see below). The model of thyroid gland construct (see inside the circle) is placed in the context of branched vascular tree bioprinting using self-assembly of vascular tissue spheroids ( figure 1(F) ). Such an approach is necessary in the case of orthotopic implantation using surgical vascular anastomoses. In the case of heterotopic implantation under a highly vascularized kidney capsule, which has been implemented in our study, the proposed bioprinting of a complete branched vascular tree is not required to achieve a desirable level of vascularization in the implanted thyroid gland construct.
A detailed description of the mathematical model and computer simulation is given as supplementary information (SI).
Generation of tissue spheroids from mouse thyroid and allantoides
Based on the self-assembly principle, we aimed to print mouse thyroid gland constructs using rounded mouse embryonic thyroid explants for the follicular compartment and rounded mouse allantois explants as a vascular, i.e. EC, source. Thyroid explants were microdissected from e14.5 mouse embryos as described in [21] and cultured overnight in a hanging drop to obtain rounded pieces of tissue suitable for bioprinting ( figure 2(A) ). It has been demonstrated previously that mouse embryonic thyroid folliculogenesis starts at e14.5 and is concomitant with vascularization of embryonic thyroid tissue [11, 21] .
Allantoides were microdissected from e8.5 mouse embryos as described in [22] and cultured overnight in a hanging drop to obtain rounding of the tissue pieces ( figure 2(B) ). Dissected e8.5 mouse allantoides have an elongated rod-like shape and consist of cells with angioblastic phenotype. It has been previously reported that isolation of allantoides at this stage with sequential incubation in hanging drop in the presence of VEGF induces endothelial differentiation and formation of a cluster of EC, with subsequent generation of blood microvessels [22] . Allantoides were thus used as a source of EC; thyroid explants as a source of follicular cells and of VEGF [21] .
When thyroid explants and allantoides were cultured in hanging drops, they took on a spherical shape overnight with mean outer diameters of 388.2 μm±45.3 (n=168) and 493.6 μm±114.3 (n=28), respectively. On assessing the circularities of AS and TS, they were estimated close to a value of 1.0, 0.92±0.06 (n=28) and 0.90±0.05 (n=168), respectively, indicating an almost perfect circle ( figure 2(C) ). This study was performed using Image J software (NIH, Bethesda, MD, USA).
Fusion of thyroid explants and allantoides in a hanging drop and within collagen hydrogel In order to investigate the capacity of TS to fuse, a pair of them of equal size were first placed in contact with each other in a hanging drop and incubated overnight (supplementary figure 1(A) ). Eighteen hours later they were found to merge together as a single spheroid (supplementary figure 1(B) ). This fusion was observed in the case of a pair of allantoides as well, incubated under similar conditions. Fusion is an inherent property of tissue spheroids, and hence this acts as a proof of principle that spheroids can be used as building blocks in our bioprinting technology.
We then evaluated the consequence of fusion of embryonic TS under conditions in which the spheroids are capable of engaging in adhesive interactions with their culture environment. For that matter, three spheroids were placed within collagen hydrogel ( figure 2(D) ). In contrast to the spherical structure generated earlier, an oviform, elongated structure was formed within the collagen. A few cells, endowed with migratory properties, left the elongated structure and invaded the 3D collagen hydrogel. The cohesiveness of the TS was measured using the fusion angle, which increased to 162°C during culture within the collagen gel indicating complete spheroid fusion ( figure 2(E) ).
We concluded that TS and AS are endowed with the property of endogenous fusion, thereby validating their use as building blocks for organ bioprinting technology. Bioprinting using mouse thyroid and allantoic spheroids For this study we developed a novel original multifunctional 3D bioprinter, Fabion ( figure 3(A) ), with two unique functional characteristics: first, it is equipped with a technology, based on the turnstile principle [31, 32] that facilitates dispensing of a single tissue spheroid at a time (figures 3(B), (C)); second, it includes a cooling/heating system for better control over the polymerization of the collagen hydrogel (supplementary figure 2) . Our system allows the use of a collagen mix with a physiological pH and prevents its premature gelation while being stored at 4°C in an extrusion needle and during the printing. The polymerization starts as soon as the hydrogel is deposited on the hot base plate, resulting in a collagen gel with a stable and predictable structure. The first step was to print a 2 mm×2 mm collagen bed on cell strainers in the Petri dish to serve as a base. After polymerization, three e14.5 TS were loaded into the print head and placed in a line and adjacent to each other on top of the collagen bed according to the mathematical model ( figure 3(D) ). We also developed a more advanced version of the bioprinted construct (TS+AS). Six e8.5 mouse AS were loaded into the printing head and printed adjacent to and on both sides of the three TS, again to mimic the mathematical model (figures 3(C), (F); compare with figure 1(E)). To complete the printing process, a thin layer of collagen hydrogel was deposited on top of three TS, or three TS with six AS, depending on the construct version.
Endothelial cells from allantoic spheroids are responsible for the vascularization of thyroid gland construct The vascularization of bioprinted thyroid gland construct is the most important and critical issue since it is required for a surrogate endocrine organ to be functional and both capture iodine and deliver hormones into the blood flow. We first analyzed the printed thyroid constructs containing TS only. After 4 days in culture, constructs were fixed and immunolabeled with antibodies against TTF1, E-cadherin and ezrin to visualize thyrocyte nuclei, basolateral and apical domains, respectively. TTF1
+ nuclei displayed a monolayered and organized circular pattern. figure 4(A″) ). However, compared with the widespread localization of EC in the TS at the end of the hanging drop culture (supplementary figure 3. ), EC were only found at the periphery of thyroid tissue after 4 days in collagen ( figure 4(A) ). This suggests that thyroid EC localized deep inside the tissue construct do not support long-term culture in collagen, probably due to low pO 2 . Interestingly, the constructs printed from TS and AS (3TS+6AS) displayed abundant and widespread localization of EC around epithelial cells of the thyroid tissue after 4 days in collagen. Ezrin and TTF1 visualization revealed developing follicular structure in thyroid tissue (figures 4(B′), (B″)). These observations suggest that endothelial progenitors present in AS responded and were attracted by the angiogenic factor, VEGF-A, highly secreted by thyrocyte progenitors of the TS [11] . However, one cannot exclude that thyroid EC responded to survival and proliferating signals secreted by the allantoides. To distinguish between these two possibilities, we cultured e14.5 thyroid explants in hanging drops in the presence of the specific VEGFR2/Flk-1 kinase inhibitor SU5416 (TS SU5416 ). As VEGFR2 signaling is essential for EC survival, inhibition of this signaling pathway leads to progressive EC death [11] . Addition of 5 μM SU5416 to the culture medium of thyroid explants for 24 h indeed removed all PECAM-positive EC from TS ( figure 4(C) ), indicating that SU5416 treatment was effective. We then bioprinted three SU5416-treated TS (TS SU5416 ) with six AS, as above, and cultured the construct in collagen hydrogel for 4 days. Bioprinted constructs showed invasion of EC deep into thyroid tissue ( figure 4(D) ), resulting in the generation of a dense capillary network surrounding epithelial cells. This indicates that EC detected around follicles on these thin sections were clearly derived from allantoides. SU5416 treatment did not affect the proliferation of thyrocytes (figures 4(C″), (D″)) or the formation of prefollicular structures (figures 4(C′), (D′), (C″), (D″)). Altogether, these experiments demonstrate that addition and fusion of allantoides to thyroid tissue within collagen hydrogels allow improved vascularization of bioprinted TS.
Bioprinted mouse thyroid gland constructs are functional in vivo In order to validate the functionality of bioprinted cultured mouse thyroid constructs (3TS+6AS), we grafted these latter under the kidney capsule of hypothyroid mice, following 131 I injection ( figure 5(A) ). Implantation of tissue pieces under the vascularized kidney capsule is a standard and wellestablished approach for in vivo testing [33] [34] [35] [36] . Experiments on hypothyroid animals were performed 8 weeks after the administration of 131 I, when all mice had undetectable blood concentrations of T4 ( figure 5(B) ). Histological evaluation of the native thyroid region 8 weeks after administration of 131 I revealed loss of thyroid tissue (supplementary figures  4(A), (B) ). The blood level of T4 was measured as a specific and most informative marker. Three and 5 weeks after grafting, recipient mice showed a substantial elevation of T4 blood levels (figure 5(C) and supplementary figure 5(A) ), indicating functional rescue with the bioprinted thyroid construct (3TS+6AS).
Additionally, we analyzed the body temperature in mice from the different groups. As expected, decreased body temperature was found in hypothyroid mice ( figure 5(D) ). Mice grafted with the printed and cultured thyroid gland construct showed a gradual normalization of body temperature at 3 and 5 weeks after transplantation, providing a reliable example for symptomatic recovery ( figure 5(E) , supplementary figure 5(B) ).
Histological evaluation of the kidney region 3 and 5 weeks after transplantation demonstrated successful integration and maturation of grafted organoids in the host niche. At the grafting site, numerous follicles containing a monolayered epithelium were present at the cortical area of the host organ ( figure 5(F) ). Regions of new capillary formation filled with erythrocytes were detectable (supplementary figure 5(C) ).
Our in vivo data clearly demonstrate that printed thyroid gland constructs have potent functional capacity to compensate for the lack of native thyroid tissue allowing functional rescue of experimentally induced hypothyroidism.
Discussion
In the present study we validated the earlier proposed principle of bioprinting technology based on the use of tissue spheroids as building blocks [5, 6] . Our data on bioprinting of functional vascularized mouse thyroid gland construct from TS and AS represents further advance in the emerging solid scaffold-free approach for 3D bioprinting, exploring self-assembling properties of tissue spheroids [6, 15, 37] . Tissue spheroids capable of fusion are already used for scaffold-free biofabrication of cartilage [38] , bone [39] , liver [40] , ovary [41] and blood vessels [9, 42] . Using tissue spheroids as opposed to single cells has substantial advantages [43, 44] . First, tissue spheroids represent densely packed spherical aggregates of living cells. Spheroids thus ensure the maximum achievable cell density during the printing, while displaying a higher resistance to shear stress, radiation and other unfavorable factors, which results in decreasing risks of karyotype alteration [45] . Secondly, precise embedding of tissue spheroids into sequentially applied layers of hydrogel ensures the desired allocation of closely placed tissue spheroids contacting each other in both horizontal and vertical directions [19] . This creates proper conditions for formation of 3D tissue constructs as a result of tissue fusion. Finally, the spherical form of tissue spheroids is ideal for their robotic dispensing through the cylindrical nozzle of 3D bioprinter.
However, tissue spheroid printing has also some drawbacks, and problems can emerge during bioprinting: (i) spontaneous fusion of spheroids resulting in the formation of clusters or aggregates seriously complicates bioprinting with individual tissue spheroids; (ii) adhesion of tissue spheroids to the walls of dispensing tubes obstructs the passage of further tissue spheroids; (iii) both the above phenomena cause undesired damage, defects, deformation and even destruction of tissue spheroids. To overcome the aforementioned problems, we created a device allowing 3D bioprinting of individual tissue spheroids, using the turnstile principle. Bioprinting achieved with our device is stable and reliable.
Collagen is a major component of the extracellular matrix, it supports cell adhesion and culture but its application in 3D bioprinting still has limitations because it is sensitive to both pH and temperature and forms a gel at physiological pH and 37°C [46] . It is thus difficult to keep a collagen mix liquid when printing and produce a solid scaffold immediately after printing [47] . The first approach to printing with collagen was changing its pH by addition of sodium hydrogen carbonate (NaHCO 3 ) before deposition to initiate the transition of collagen solution to a gel when the temperature gradually increases during the printing. Although this system improved deposition of the hydrogel by the bioprinter, the process was time consuming, resulting in clogging inside the extrusion needle due to anticipatory polymerization caused by gradual transition to room temperature. We improved the printing of collagen hydrogel by implementing a cooling/heating system in our extrusion bioprinter, which had been previously used [48] , but its biocompatibility was not evaluated.
Bioprinting of thyroid gland construct containing a dense network of EC is another important achievement of this study. 3D bioprinted tissue constructs quickly develop necrotic regions without sufficient vascularization [49] . Printing the channels from sacrificial hydrogels followed by the seeding of EC and smooth muscle cells for vessel wall formation is an approach developed recently [13, 50] . Carbohydrate glass [13] or pluronic acid F-127 [50] was used to print sacrificial tunnels within a supporting matrix and then extruded by dissolution, leaving room for EC population. This approach is highly effective and reproducible for simple homogeneous constructs. However, natural tissues and organs are effectively perfused by a hierarchically branched complex intraorgan vascular tree. These will be difficult to mimic using sacrificial matrices. In this study we employed the self-assembly approach which represents an alternative to the scaffold-free technique for engineered tissue vascularization. It has been demonstrated that large-diameter blood vessels could be bioprinted from vascular tissue spheroids biofabricated from smooth muscle cells and EC [43] . The capacity of lumenized vascular AS to fuse into linear and branched intermediate-diameter vascular segments has been reported [6] . Finally, the microvascular networks can be self-assembled either from single cells placed into hydrogel by vacuole accumulation [51] or from endothelial tissue spheroids [52] . Thus, all three main parts of the intra-organ branched vascular tree-large-diameter vessel segments, intermediate-diameter vascular segments and microvascular segments-could be bioprinted using vascular tissue spheroids as building blocks.
In the present study we showed that sufficient development of a microvascular network could be achieved in the engineered tissue construct by placing AS adjacent to TS, known to produce high levels of VEGF-A [11] . Indeed, we found that the endothelial density was more prominent in AS+TS than in TS alone. More importantly, TS depleted of EC were effectively invaded by EC when AS were added in the engineered construct. The presence of a dense microvascular network is not only significant for survival of the cells upon in vivo grafting. In the developing thyroid, EC invasion, from e12.5 onwards also positively controls the induction of thyroid folliculogenesis by promoting basal lamina deposition [11, 24] . Thus, allantoides-derived 'vasculature' could contribute to advancing thyroid folliculogenesis and sequential differentiation and maturation of follicles in the thyroid gland construct. Most importantly, better survival and expansion of EC from AS could allow formation of large, intermediate and microvessels in the construct, thereby allowing functional connection with the vascularization from the host mice. Taken together these results strongly support the practical feasibility of developing vascularized-competent tissue using bioprinting of vascular tissue spheroids. It should not escape to our attention that the advance in bioprinting of functional tissue depends on our understanding of the principles of cellular self-assembly and the ability to take advantage of this knowledge.
The thyroid gland construct must include the artery and the vein to establish anastomosis with the vascular system of the receiving organism. This is important for orthotopic implantation, when the printed construct is to be transplanted to the usual thyroid gland site. However, this is not critical if the implantation is heterotopic. It is well known that thyroid gland transplants can survive under the skin, in muscles or under the kidney capsule and still produce hormones [53, 54] . In case of heterotopic implantation under highly vascularized kidney capsula there is no need for large-diameter blood vessels connected to the bioprinted thyroid gland construct. Our results suggest that the connection of the microvascular network from the bioprinted construct, with that of the kidney capsula allows vascularization of the thyroid follicles.
Validation of the functionality of bioprinted mouse thyroid gland construct is another significant result of our study. Grafting of the bioprinted mouse thyroid construct under the kidney capsula of hypothyroid mice restored blood T4 level and body temperature, demonstrating functionality of bioprinted mouse thyroid construct. The amplification of TS, improvement of thyroid follicle vascularization and the level of their histological differentiation and maturation should eventually achieve 100% rescue of lost function in athyroid mice.
A consistent question arises concerning the possible clinical translation of our proposed variant of bioprinting technology. In order to bioprint human thyroid tissue in the future it is necessary to have clinically relevant source of therapeutic-grade thyroid epithelial cells. However, the effective propagation and scalable generation of large number of autologous differentiated human thyroid epithelial cells from biopsy is still a challenge. As of today, our efforts to isolate and propagate human thyroid epithelium or even viable thyroid follicles directly from human thyroid gland have not been successful (data not shown). So this direct approach is looking increasingly elusive and practically unfeasible. In this context, scalable generation of functional thyroid epithelium from human stem cells looks much more promising. The reported generation of thyroid follicles at first from mouse embryonic stem cells [25] , then from human embryonic stem cells [55] , and most recently, from human induced pluripotent stem cells [56] opens an opportunity for bioprinting of human thyroid gland. Tissue spheroids biofabricated from human smooth muscle and EC could be successfully generated from human fat tissue stem cells [57] or from human induced pluripotent stem cells using directed tissue differentiation [58, 59] . Alternatively, it would be possible to employ human endothelial tissue spheroids, which are capable of forming a vascular network in vitro and in vivo [52, 60] . Autologous EC could be isolated in sufficient number from human fat tissues [61] . Thus, 3D bioprinting of thyroid human tissue from organo-specific tissue spheroids and vascular tissue spheroids capable of post-printing tissue fusion is technologically feasible.
Conclusion
A thyroid gland construct has been bioprinted using two types of rounded embryonic tissue spheroids: thyroid spheroids were printed in close association with allantoic spheroids within collagen hydrogel using a novel bioprinter capable of precise placing of one spheroid at a time. Within 4 days, tissue spheroids fused into a single and integral thyroid gland construct, in which endothelial cells from allantoic spheroids invaded and vascularized thyroid spheroids, generating a dense capillary network around developing follicles. The bioprinted construct is functional as it could restore thyroid homeostasis after grafting under the kidney capsule of hypothyroid mice. Thus, our data demonstrated that bioprinting of tissue spheroids (i) derived from dissected embryonic mouse tissues, (ii) used as building blocks and (iii) capable of fusion can develop in vascularized-competent thyroid gland construct, functional in vivo. Our data represent a significant advance in the development of organ printing technology and important step toward eventual bioprinting of vascularized functional human tissue.
